Michael Lipp

Chief Technology Officer Decoy Therapeutics

Seminars

Tuesday 28th April 2026
Spotlight Case Study 2: Design & Development of Peptide Conjugate Antiviral Therapeutics
Michael Lipp
View all Speakers
View Event Brochure